Bio Manufacturing of the Future requires cost effective, scalable solutions that can be implemented quicker than the traditional stainless steel facilities of yesterday. This session explores aspects of bio manufacturing that challenge the status quo and push the boundaries of bio manufacturing as we know it. From continuous methodologies to disposable technologies, we explore the industries response to the bio manufacturing capacity challenge.
Sr Director Engineering API/DP,
Eli Lilly & Co
Vice President Strategic Program Management Lead - BioTech,
Executive Technical Director |Advanced Technologies & Life Sciences,
Fluor Life Sciences
Vice President/General Manager - BioProcess Single Use and Enterprise,